American International Group, Inc. Eq Rx, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $9,398 - $13,079	5,662 Added 3.69%	159,246 $353,000
Q2 2023 Aug 04, 2023	BUY	$1.61 - $1.96 $91,059 - $110,855	56,559 Added 58.29%	153,584 $285,000
Q1 2023 May 12, 2023	BUY	$1.8 - $2.83 $3,474 - $5,461	1,930 Added 2.03%	97,025 $188,000
Q4 2022 Feb 10, 2023	SELL	$2.05 - $5.5 $709 - $1,903	-346 Reduced 0.36%	95,095 $233,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $29,554 - $188,331	31,441 Added 49.13%	95,441 $472,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $204,800 - $364,160	64,000 New	64,000 $300,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.